Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tecarfarin sodium by Cadrenal Therapeutics for Thrombosis: Likelihood of Approval
Tecarfarin sodium is under clinical development by Cadrenal Therapeutics and currently in Phase I for Thrombosis. According to GlobalData, Phase...